Related references
Note: Only part of the references are listed.The need to distinguish intervention thresholds and diagnostic thresholds in the management of osteoporosis
John A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2023)
A broader strategy for osteoporosis interventions
Ian R. Reid
NATURE REVIEWS ENDOCRINOLOGY (2020)
Performance of FRAX and FRAX-Based Treatment Thresholds in Women Aged 40 Years and Older: The Manitoba BMD Registry
Carolyn J. Crandall et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Adjuvant zoledronic acid reduces fractures in breast cancer patients; an AZURE (BIG 01/04) study
C. Wilson et al.
EUROPEAN JOURNAL OF CANCER (2018)
Fracture Prevention with Zoledronate in Older Women with Osteopenia
Ian R. Reid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial
Michael Gnant et al.
LANCET (2015)
The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group
E. S. Siris et al.
OSTEOPOROSIS INTERNATIONAL (2014)
The diagnosis of osteoporosis
John A. Kanis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
A reference standard for the description of osteoporosis
John A. Kanis et al.
BONE (2008)
Cost-effective osteoporosis treatment thresholds: the United States perspective
A. N. A. Tosteson et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Effects of raloxifene on fracture risk in postmenopausal women: The raloxifene use for the heart trial
Kristine E. Ensrud et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: Results of a double-blind, placebo-controlled randomized study
Eugene V. McCloskey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Effects of estrogen plus progestin on risk of fracture and bone mineral density - The Women's Health Initiative randomized trial
JA Cauley et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Diagnosis of osteoporosis and assessment of fracture risk
JA Kanis
LANCET (2002)